Tag Archives: clinical study

Doctornauts Barry Marshall and Lukas Wartman: Living Proof of the Urgent Need for the Doctornaut Act

In my first book, Drug Discovery, The Pending Crisis, published way back in 1972, I wrote, “Our present system of drug discovery is almost designed not to cure the great diseases that confront us. There is no doubt that many will be cured in the distant future, but it is unfortunate that many of us […]

Read more

The patient always get screwed

If you’re presently or a future patient, are you aware that our health care system is designed to keep you as a patient with your disease or disability for a long time? There’s talk about health care everywhere but are you aware that you, the patient, as in the past, has not been included in […]

Read more

The Cardiovascular Promise of Vitamin E is Still Alive: Here’s Why and Here’s What to Do.

In the early 80’s, animal studies supported the idea that vitamin E can prevent heart attacks and stroke. In rodents and piglets this vitamin caused a dramatic reduction of arterial plaque size. In the early 90’s large clinical studies reported that vitamin E did indeed cause a reduction in cardiovascular events. It was believed that […]

Read more

Magnesium and Diabetic Patients: Should You take it?

Over 25 years ago I became somewhat curious about magnesium as companion to carnitine for the treatment of coronary heart disease. As chance would have it, a company approached me with a patented magnesium formulation and asked me to find a company which would develop it- not an easy task in those days, let alone […]

Read more

Carnitine, Coronary Heart Disease-Myocardial Ischemia and Diabetes

Carnitine is a naturally occurring extremely safe substance found in most human cells. It is, by far, the most widely researched cardiac nutraceutical regarding how it protects the heart against a lack of oxygen which occurs before a non-fatal or fatal heart attack. Doctors refer to this lack of oxygen as myocardial ischemia. Here’s how […]

Read more

Response to Carolyn from MyHeartSisters.org

NOTE: We encourage you to read the substantial comment left by Carolyn Thomas, who writes over at http://www.myheartsisters.org. The comment was written on Dr. DeFelice’s previous post on the cardiovascular promise of vitamin E. The note below is in response to her remarks. Dear Mrs. Thomas, The nutrition world is confusing and for a number of reasons, […]

Read more

Why aren’t Hypertensive patients mad?

Renal Denervation: Exciting Promise for the Treatment of Drug- Resistant Hypertension. Why Aren’t Hypertensive Patients Mad? Another Reason for the Doctornaut Act Currently, in the United States alone there are approximately 76 million  hypertensive patients, about 9 million of whom are resistant to drug therapy making them highly vulnerable to heart attacks, strokes and heart […]

Read more

VIDEO: Nutraceutical industry needs new trial design culture

Dr. DeFelice sat down with the respected NutraIngredients.com reporter Shane Starling to talk about the state of the nutraceutical industry and the need for a new design culture. The multi-billion euro global nutraceutical industry will never achieve its potential until it better adapts pharma protocols – and this can be done with food nutrients, says […]

Read more

The Potential Nutraceutical Market

Stephen L. DeFelice, M.D., just finished speaking at the 2012 Vitafoods Conference in Geneva, Switzerland. In his speech he spoke about the potential for a nutraceutical market, and the state of the current traditional dietary supplement and food markets. Dr. DeFelice also wrote a paper on the same subject, take a look at it below. The picture […]

Read more

Vitafoods Europe Conference This Week!

This week, Dr. DeFelice is joining thousands of highly respected doctors, business leaders, and nutritionists at the annual Vitafoods Europe conference. If you haven’t done it already, check out the Vitafoods website for more information about this annual event. After Dr. DeFelice’s presentation on the future of nutraceuticals, we’ll be posting a paper he wrote for […]

Read more